Nebraska

Executive Order No. 21-18 Continued Waivers to Facilitate Hospital Planning and Ensure Additional HealthCare Workforce Capacity expired on March 31. Executive Order No. 21-18 extended Executive Order 21-15 Further Health Care Workforce Capacity that permitted pharmacists to have any number of pharmacist interns and pharmacy technicians under their supervision when administering vaccinations. Beginning April 1, the ratio reverts to pre-pandemic levels.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-01T12:22:24-04:00April 1, 2022|Nebraska|

North Carolina

Statewide standing orders issued by Dr. Betsey Tilson, State Health Director, for the administration of nicotine replacement, contraceptives, post-exposure prophylaxis medications for the prevention of human immunodeficiency virus (HIV), glucagon for the treatment of severe hypoglycemia, naloxone and COVID related treatments have been updated, organized, and can be found here.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-01T12:20:01-04:00April 1, 2022|North Carolina|

Oregon

The Board of Pharmacy adopted the following:  

Also in Oregon, the Board of Pharmacy posted its agenda and meeting materials for its next meeting scheduled for April 13-15.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-01T12:10:03-04:00April 1, 2022|Oregon|

Tennessee

Notice from TennCare, prior authorization (PA) requirements can be bypassed for certain medications when specific medical conditions exist. Those specific medications and diagnoses can be found here. Prescribers are encouraged to include the applicable diagnosis code on written prescriptions for inclusion on the electronic pharmacy claim. The submitted claim should include a Diagnosis Code Qualifier (Field # 492- WE) of “02,” indicating ICD-10, as well as the appropriate Diagnosis Code (Field # 424-DO). Note: A list of the preferred agents and the clinical criteria can be found here.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-01T12:03:29-04:00April 1, 2022|Tennessee|

Texas

The Board of Pharmacy (TSBP) issued a reminder notice on the proper destruction and disposal of prescription medications. For dangerous drugs destruction, a TSBP licensed pharmacist is authorized to destroy stock so that it is unfit for human consumption and disposed of in compliance with all applicable state and federal requirements. 

Also in Texas, TSBP’s COVID website includes a chart comparing the authorizations in the PREP Act amendments with the Texas statutes and rules.  

Finally in Texas, the Health, and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) issued the biannual specialty drug list. Members should contact vdp-formulary@hhsc.state.tx.us with comments or any questions. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-04-01T12:00:08-04:00April 1, 2022|Texas|

Vermont

The Department of Vermont Health Access (DVHA) is implementing changes to its prescription drug benefits programs to ensure Medicaid patients continue to have access to the medications they need for conditions related to COVID-19. The changes center around copayments, prescription instructions, and approved medication treatments. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-04-01T11:58:20-04:00April 1, 2022|Vermont|

West Virginia

Governor Justice (R) has signed two bills aimed at the regulation of Pharmacy Benefit Managers (PBMs). SB 312 provides legislative approval for Rules promulgated by the Insurance Commission to enact HB 2263 of 2021, landmark legislation that sets a reimbursement floor and provides a level playing field for community pharmacy. HB 4112 provides for pharmacy freedom of choice for specialty drugs, addresses 340B programs and will be effective for policies executed, amended or renewed on or after Jan. 1, 2023.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-04-01T11:52:03-04:00April 1, 2022|West Virginia|
Go to Top